medline.ch Respirationstrakt Zystische Fibrose

	Dual inhaled antibiotics for treatment of pulmonary exacerbations in cystic fibrosis - A real life pilot study. Respir Med Res Heching M, Slomianksy L, Mussaffi H, Prais D, Weinberg J, Kramer MR. PMID: 39053340 [PubMed - as supplied by publisher]
	Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study. Ann Am Thorac Soc Yaacoby-Bianu K, Dagan A, Cohen-Cymberknoh M, Tsviban L, Gur M, Golan-Tripto I, Aviram M, Stein N, Shteinberg M, Kerem E, Livnat G. PMID: 39052004 [PubMed - as supplied by publisher]
	Cystic Fibrosis: Understanding Cystic Fibrosis Transmembrane Regulator Mutation Classification and Modulator Therapies. Adv Respir Med Anwar S, Peng JL, Zahid KR, Zhou YM, Ali Q, Qiu CR. PMID: 39051188 [PubMed - indexed for MEDLINE]
	The Impact of Cost of Living on the Quality of Life of Cystic Fibrosis Patients: A Study in Greece. Cureus Dainavas D, Stergiannis P, Manthou P, Lioliousis G, Diamantea F, Myrianthefs P, Fildissis G. PMID: 39050347 [PubMed]
	Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale. BMC Pulm Med Gill ER, Goss CH, Sagel SD, Wright ML, Horner SD, Zuñiga JA. PMID: 39049032 [PubMed - indexed for MEDLINE]
	Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa After Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis. Ann Am Thorac Soc Mayer-Hamblett N, Gifford AH, Kloster M, Russell R, Braun AT, Gibson RL, Hoppe JE, Jain R, Linnemann RW, Liou TG, Lysinger J, Milla C, Riekert KA, Sawicki GS, Young J, Nichols D. PMID: 39041864 [PubMed - as supplied by publisher]
	Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics. ERJ Open Res Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, Mange K, Teper A, Fernandez C, Conroy D, Metersky M. PMID: 39040578 [PubMed]
	Cystic fibrosis hepatobiliary involvement: an update on imaging in diagnosis and monitoring. Pediatr Radiol Wood W, Tinich T, Lazar L, Schooler GR, Sathe M. PMID: 39039200 [PubMed - as supplied by publisher]
	Zinc status in cystic fibrosis patients; a systematic review and meta-analysis. Heliyon Malekahmadi M, Soltani S, Pahlavani N, Sharifi Zahabi E, Kazemizadeh H, Hadavi S, Farsani GM. PMID: 39027558 [PubMed]
	What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review. Respir Investig Naseem R, Howe N, Williams CJ, Pretorius S, Green K. PMID: 39024929 [PubMed - as supplied by publisher]
	The predictive role of lung clearance index on FEV(1) decline in cystic fibrosis. Turk J Pediatr Özsezen B, Yalç, Emiralio, Kon, Ademhan Tural D, Caka C, Sunman B, Do, Özçelik U, Kiper N. PMID: 39024602 [PubMed - indexed for MEDLINE]
	The relationship between lung function, exercise capacity, oxidant and antioxidant response in primary ciliary dyskinesia and cystic fibrosis. Turk J Pediatr Kartal Y, Bozdemir Özel C, Çakmak A, Sonbahar Ulu H, , Ademhan Tural D, Ery, H, Özçelik U, Karahan S, Budak MT, Girgin G, Ar, Sabuncuo. PMID: 39024596 [PubMed - indexed for MEDLINE]
	Detection of Specific IgE against Molds Involved in Allergic Bronchopulmonary Mycoses in Patients with Cystic Fibrosis. Mycopathologia Barrera C, Schwarz C, Delhaes L, Le Gal S, Ramel S, Gangneux JP, Guitard J, Hoffmann C, Bellanger AP, Bouchara JP, Millon L. PMID: 39023843 [PubMed - indexed for MEDLINE]
	Characterization of bone disease in cystic fibrosis. Med Clin (Barc) Contreras-Bolívar V, Andreo-López MC, Muñoz-Torres M. PMID: 39019666 [PubMed - as supplied by publisher]
	Burkholderia cepacia in cystic fibrosis children and adolescents: overall survival and immune alterations. Front Cell Infect Microbiol Shmarina G, Pukhalskaya D, Shmarin V, Semykin S, Avakyan L, Krasovsky S, Goryainova A, Kostyuk S, Zinchenko R, Kashirskaya N. PMID: 39011515 [PubMed - indexed for MEDLINE]
	Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Int J Antimicrob Agents Wang Z, De Soir S, Glorieux A, Merabishvili M, Knoop C, De Vos D, Pirnay JP, Bambeke FV. PMID: 39009289 [PubMed - as supplied by publisher]
	Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis. Thorax Cuyx S, Ramalho AS, Fieuws S, Corthout N, Proesmans M, Boon M, Arnauts K, Carlon MS, Munck S, Dupont L, De Boeck K, Vermeulen F, Belgian Organoid Project. PMID: 39004507 [PubMed - as supplied by publisher]
	Testosterone concentrations and associated predictors in men with cystic fibrosis: a retrospective, single-center study. Am J Med Sci Jathal I, Wang Y, Binongo JNG, Cobb C, Hunt WR, Khan FN, Tangpricha V. PMID: 38997066 [PubMed - as supplied by publisher]
	Advances in diabetes technology to improve the lives of people with cystic fibrosis. Diabetologia Scully KJ, Marks BE, Putman MS. PMID: 38995399 [PubMed - as supplied by publisher]
	A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass. J Clin Endocrinol Metab Piona C, Mozzillo E, Tosco A, Zusi C, Emiliani F, Volpi S, Di Candia F, Raia V, Boselli ML, Trombetta M, Cipolli M, Bonadonna RC, Maffeis C. PMID: 38994570 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 18562

Seite 1 von 929



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung